BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND TTL, 2410003M22Rik, 150465, ENSG00000114999, MGC46235, Q8NG68
7 results:

  • 1. Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas.
    Barreca M; Spanò V; Rocca R; Bivacqua R; Abel AC; Maruca A; Montalbano A; Raimondi MV; Tarantelli C; Gaudio E; Cascione L; Rinaldi A; Bai R; Steinmetz MO; Prota AE; Alcaro S; Hamel E; Bertoni F; Barraja P
    Eur J Med Chem; 2022 Dec; 243():114744. PubMed ID: 36242921
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Novel model predicts prognosis for patients with diffuse large B-cell lymphoma in first relapse after initial R-CHOP therapy: a single-institution study in China.
    Wang W; Yin J; Zhang W; Zhang Y; Zhou D; Zhao D; Wei C
    J Int Med Res; 2021 Apr; 49(4):3000605211002971. PubMed ID: 33845607
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemia.
    Alruwetei AM; Bendak K; Yadav BD; Carol H; Evans K; Mayoh C; Sutton R; Marshall GM; Lock RB
    Br J Cancer; 2020 Sep; 123(5):742-751. PubMed ID: 32536690
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Early relapse in ALL is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathways.
    Meyer LH; Eckhoff SM; Queudeville M; Kraus JM; Giordan M; Stursberg J; Zangrando A; Vendramini E; Möricke A; Zimmermann M; Schrauder A; Lahr G; Holzmann K; Schrappe M; Basso G; Stahnke K; Kestler HA; Te Kronnie G; Debatin KM
    Cancer Cell; 2011 Feb; 19(2):206-17. PubMed ID: 21295523
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of a novel fusion gene, ttl, fused to ETV6 in acute lymphoblastic leukemia with t(12;13)(p13;q14), and its implication in leukemogenesis.
    Qiao Y; Ogawa S; Hangaishi A; Yuji K; Izutsu K; Kunisato A; Imai Y; Wang L; Hosoya N; Nannya Y; Sato Y; Maki K; Mitani K; Hirai H
    Leukemia; 2003 Jun; 17(6):1112-20. PubMed ID: 12764377
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia.
    Liu Q; Schwaller J; Kutok J; Cain D; Aster JC; Williams IR; Gilliland DG
    EMBO J; 2000 Apr; 19(8):1827-38. PubMed ID: 10775267
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Intensive combination chemotherapy (ttl-I protocol) of large cell and immunoblastic lymphomas--long-term observation.
    Koza I; Mardiak J; Bohunický L; Svancárová L; Fuchsberger P; Gyárfás J; Horák I; Spánik S; Sufliarsky J; Thalmeinerová Z
    Neoplasma; 1992; 39(1):43-7. PubMed ID: 1382234
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.